Purchases and Sales Made in Q2 2024 in Nektar Therapeutics (NKTR)
This table provides information about the institutional ownership of Nektar Therapeutics (NKTR) during Q2 2024. The information is specifically focused on institutions that hold shares of NEKTAR THERAPEUTICS.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-606K- 66.36% |
$545K - $1.11M
|
307K
$252K
|
|
|
Aug 09, 2024
Q2 2024
|
Primecap Management CO
Pasadena, CA |
SELL
|
- |
-946K- 13.58% |
$852K - $1.73M
|
6.02M
$4.94M
|
|
|
Aug 15, 2024
Q2 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-1.06M- 53.22% |
$953K - $1.94M
|
931K
$763K
|
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-1.31M- 28.28% |
$1.18M - $2.39M
|
3.31M
$2.72M
|
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-2.2M- 86.4% |
$1.98M - $4.03M
|
347K
$284K
|
|
|
Aug 06, 2024
Q2 2024
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-2.68M- 35.47% |
$2.42M - $4.91M
|
4.88M
$4.01M
|
|
|
Aug 07, 2024
Q2 2024
|
Monaco Asset Management Sam
|
SELL
|
- |
-3.67M- 62.85% |
$3.3M - $6.71M
|
2.17M
$1.78M
|